INSIGHTS ON CLINICAL TRIAL DESIGN

• The Strategic Backbone Of Marketing Application Success

  Through proactive timeline management and strategic oversight, organizations can achieve their regulatory goals with confidence.

• Simplifying ePRO Data Collection

  The Bring Your Own Device (BYOD) model, supported by Trialkit, is an innovative approach in clinical trials that allows participants to use personal smartphones or tablets for data collection.

• De-Risking Early-Stage Biotech: Turning Vision Into Venture Capital

  For early-stage biotech companies, transforming a scientific breakthrough into an investable asset requires more than compelling data—it requires a clear product vision.

• Key Strategies For Clinical Development In Rare Cancers

  Successful execution of rare cancer clinical trials requires strategic patient recruitment, innovative trial design, and specialized expertise from Oncology CROs.

• The Future Of Patient Participation In Clinical Research

  2/18/2025

  To address challenges such as limited patient awareness, mistrust, and logistical barriers, the industry must embrace technology-driven solutions and community-centered outreach.

• Investigator SmartSelect

  10/23/2024

  This advanced recommendation engine identifies protocol-specific investigators in just minutes, dramatically shortening a process that typically takes four to six weeks.

• EDC Powers End-To-End Data Management In Pharma-Sponsored Trials

  9/4/2025

  As clinical research moves toward adaptive, decentralized, and data-rich models, EDC remains the backbone that makes innovation operationally feasible.

• Driving Diversification And Reach With Tech In Community DCTs

  3/20/2025

  Learn how technology, when used correctly, can accelerate trial timelines and drive patient diversification in community-based decentralized clinical trials (DCTs).

• 5 Common Misconceptions About Mobile Visits In Clinical Trials

  10/11/2024

  In this article, we address five key misconceptions about mobile research services, including concerns about inconsistent nurse assignments, privacy risks, and limited applications for complex protocols.